EMERALD ADVISERS, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 91 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$24,920,000
-33.6%
171,023
-45.9%
1.28%
-10.4%
Q1 2022$37,514,000
+6.0%
316,386
+23.3%
1.43%
+9.6%
Q4 2021$35,376,000
+23.0%
256,700
+24.0%
1.30%
+25.0%
Q3 2021$28,755,000
+311.1%
207,006
+153.6%
1.04%
+350.0%
Q4 2020$6,995,000
-45.8%
81,616
-58.9%
0.23%
-56.3%
Q3 2020$12,901,000
-64.4%
198,452
-60.0%
0.53%
-66.4%
Q2 2020$36,242,000
+83.4%
495,719
-14.6%
1.58%
+38.1%
Q1 2020$19,761,000
-24.6%
580,679
+20.6%
1.14%
+3.3%
Q4 2019$26,213,000
+98.4%
481,494
+52.1%
1.11%
+79.4%
Q3 2019$13,210,000
-10.7%
316,646
-6.2%
0.62%
+3.9%
Q2 2019$14,786,000
-51.5%
337,650
-43.0%
0.59%
-52.1%
Q1 2019$30,511,000
+44.7%
592,793
+4.0%
1.24%
+19.7%
Q4 2018$21,085,000
-3.3%
570,168
-1.8%
1.04%
+29.5%
Q3 2018$21,795,000
+36.0%
580,413
+43.2%
0.80%
+32.6%
Q2 2018$16,020,000
+71.2%
405,364
+11.6%
0.60%
+61.1%
Q1 2018$9,357,000
-6.2%
363,249
-1.8%
0.38%
-2.3%
Q4 2017$9,977,000
+9.7%
369,782
+52.0%
0.38%
+3.8%
Q3 2017$9,096,000
-26.9%
243,327
-51.1%
0.37%
-28.8%
Q2 2017$12,447,000497,8800.52%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders